ERBB2 and breast cancer: Clinically, depending on the expression status of estrogen receptor (ER), progesterone receptor (PR) and ERBB2 receptor (HER-2), BC can be classified into four major subtypes including luminal A (ER positive and/or PR positive, HER-2 negative), luminal B (ER positive and/or PR positive, HER-2 positive), HER2 (ER negative, PR negative, HER-2 positive), basal-like (ER negative, PR negative, HER-2 negative)11,12.